The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2014

Filed:

Oct. 03, 2008
Applicants:

Luke A. Esposito, Seattle, WA (US);

F. Michael Hudson, Seattle, WA (US);

Thomas Lake, Snohomish, WA (US);

Joel Cummings, Seattle, WA (US);

Manfred Weigele, Cambridge, MA (US);

Alan D. Snow, Lynnwood, WA (US);

Lesley Larsen, Dunedin, NZ;

Inventors:

Luke A. Esposito, Seattle, WA (US);

F. Michael Hudson, Seattle, WA (US);

Thomas Lake, Snohomish, WA (US);

Joel Cummings, Seattle, WA (US);

Manfred Weigele, Cambridge, MA (US);

Alan D. Snow, Lynnwood, WA (US);

Lesley Larsen, Dunedin, NZ;

Assignee:

Proteotech Inc, Kirkland, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4196 (2006.01); A61K 31/4164 (2006.01); A61K 31/18 (2006.01); A61K 31/05 (2006.01); C07D 249/08 (2006.01); C07D 233/54 (2006.01); C07C 311/29 (2006.01); C07C 39/10 (2006.01);
U.S. Cl.
CPC ...
C07C 311/29 (2013.01); C07D 249/08 (2013.01); C07D 233/54 (2013.01); C07C 39/10 (2013.01); A61K 31/4196 (2013.01); A61K 31/4164 (2013.01); A61K 31/18 (2013.01); A61K 31/05 (2013.01);
Abstract

Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of β-amyloid diseases, such as observed in Alzheimer's disease, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.


Find Patent Forward Citations

Loading…